Healthcare provider profile · identity verified

Robert J Warden, M.D.

Internal Medicine · CINCINNATI, OH · NPI 1881696599

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1034	261
Amlodipine Besylate	Amlodipine Besylate	427	111
Losartan Potassium	Losartan Potassium	403	92
Levothyroxine Sodium	Levothyroxine Sodium	374	89
Lisinopril	Lisinopril	339	90
Rosuvastatin Calcium	Rosuvastatin Calcium	334	93
Tamsulosin Hcl	Tamsulosin Hcl	272	67
Metformin Hcl Er	Metformin Hcl	261	63
Trazodone Hcl	Trazodone Hcl	242	54
Eliquis	Apixaban	233	46
Gabapentin	Gabapentin	224	42
Pantoprazole Sodium	Pantoprazole Sodium	222	52
Duloxetine Hcl	Duloxetine Hcl	212	50
Omeprazole	Omeprazole	209	56
Metoprolol Succinate	Metoprolol Succinate	169	43
Simvastatin	Simvastatin	168	44
Allopurinol	Allopurinol	150	40
Ezetimibe	Ezetimibe	134	41
Escitalopram Oxalate	Escitalopram Oxalate	128	33
Hydrochlorothiazide	Hydrochlorothiazide	107	29
Carvedilol	Carvedilol	103	27
Meloxicam	Meloxicam	103	34
Sertraline Hcl	Sertraline Hcl	95	26
Pravastatin Sodium	Pravastatin Sodium	94	25
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	90	77
Methylprednisolone	Methylprednisolone	89	79
Potassium Chloride	Potassium Chloride	83	22
Valsartan	Valsartan	81	19
Jardiance	Empagliflozin	79	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	74	18
Furosemide	Furosemide	71	20
Fluticasone Propionate	Fluticasone Propionate	70	30
Synthroid	Levothyroxine Sodium	69	18
Clopidogrel	Clopidogrel Bisulfate	66	14
Zolpidem Tartrate	Zolpidem Tartrate	66	19
Albuterol Sulfate Hfa	Albuterol Sulfate	64	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	58	17
Donepezil Hcl	Donepezil Hcl	57	15
Finasteride	Finasteride	56	18
Metformin Hcl	Metformin Hcl	55	11
Tizanidine Hcl	Tizanidine Hcl	53	25
Lorazepam	Lorazepam	52	16
Azithromycin	Azithromycin	50	43
Famotidine	Famotidine	50	13
Ozempic	Semaglutide	49	11
Spironolactone	Spironolactone	47	12
Bupropion Xl	Bupropion Hcl	44	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	43	38
Dutasteride	Dutasteride	41	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	40	suppressed
Alprazolam	Alprazolam	39	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	39	11
Buspirone Hcl	Buspirone Hcl	39	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	11
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Torsemide	Torsemide	36	suppressed
Atenolol	Atenolol	35	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Cefuroxime	Cefuroxime Axetil	34	29
Tramadol Hcl	Tramadol Hcl	34	11
Mirtazapine	Mirtazapine	33	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	32	11
Calcitriol	Calcitriol	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	11
Primidone	Primidone	31	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Trulicity	Dulaglutide	29	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	28	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Midodrine Hcl	Midodrine Hcl	27	suppressed
Rivastigmine	Rivastigmine	27	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	26	25
Prednisone	Prednisone	26	23
Triamcinolone Acetonide	Triamcinolone Acetonide	26	20
Methocarbamol	Methocarbamol	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	15
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Ramipril	Ramipril	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Testosterone Cypionate	Testosterone Cypionate	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Amoxicillin	Amoxicillin	23	18
Benazepril Hcl	Benazepril Hcl	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	22	suppressed
Valacyclovir	Valacyclovir Hcl	21	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Clonazepam	Clonazepam	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	11
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Levemir Flexpen	Insulin Detemir	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Arnuity Ellipta	Fluticasone Furoate	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Fenofibrate	Fenofibrate,micronized	18	suppressed
Meclizine Hcl	Meclizine Hcl	17	13
Nitroglycerin	Nitroglycerin	17	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Prolia	Denosumab	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Levofloxacin	Levofloxacin	14	12
Pregabalin	Pregabalin	14	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Niacin Er	Niacin	13	suppressed
Risedronate Sodium	Risedronate Sodium	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Victoza 3-Pak	Liraglutide	13	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Klor-Con	Potassium Chloride	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error